Bio-Rad Reports First-Quarter 2015 Financial Results

Go back to Bio-Rad Reports First-Quarter 2015 Financial Results

Bio-Rad Labs (BIO) PT Lifted to $165 at Jefferies

May 6, 2015 8:09 AM EDT

Jefferies analyst Brandon Couillard reiterated a Buy rating and lifted his price target on Bio-Rad Labs (NYSE: BIO) to $165.00 (from $150.00) following much better-than-expected Q1 results.

Couillard commented, "BIO's 1Q15 EPS of $0.61 dusted our view ($0.36) on vastly better profitability, despite a sizable... More

Bio-Rad Labs (BIO) Tops Q1 EPS by 28c

May 5, 2015 4:41 PM EDT

Bio-Rad Labs (NYSE: BIO) reported Q1 EPS of $0.61, $0.28 better than the analyst estimate of $0.33. Revenue for the quarter came in at $472.8 million versus the consensus estimate of $474.6 million.

For earnings history and earnings-related data on Bio-Rad Labs (BIO) click here.

... More